Alameddine Rima

CRO Alameddine Rima sold 100,000 shares of IONQ at $46.89; stock now $41.71, down 49.2% from 52-week high.

Rima sold 100,000 shares (18.8% of her pre-transaction holdings) at $46.89 on 2025-11-20, retaining 432,616 shares post-sale. The sale occurred near the middle of IONQ's 52-week range and well before the current price of $41.71, which is 49.2% below the 52-week high of $82.09. Examining timing context: across her cross-ticker track record, Rima's 6 prior sells have averaged +9.6% 30-day return and +6.2% 90-day return, with a well-timed rate of 40.00%, suggesting modest success predicting downturns. At IONQ specifically, her prior 5 trades show mixed timing—only 1 of 4 measurable 90-day outcomes was well-timed (negative return), with her most recent IONQ sale on 2025-09-11 posting +59.1% 30-day return (poorly timed). The company remains unprofitable with $-1.1B net income over its latest full fiscal year, though annual revenue growth is strong at 95.4%, creating a disconnect between near-term fundamentals and valuation. The 30-day decline of 24.8% post-transaction and the stock's recent weakness merit observation against her historical track record at this ticker.

CRO Rima sells 19,976 shares at $44.40 on IONQ; stock now at 52-week high $55.61

Alameddine Rima, Chief Revenue Officer, sold 19,976 shares at $44.40 on 2025-09-11, reducing holdings from 552,592 to 532,616 shares—a -3.6% reduction. The sale occurred at a price 20% below the current market level of $55.61, which is at the 52-week high. IonQ is unprofitable with net income of $-176,838,000.00 on quarterly revenue of $20,694,000.00, though the company exhibits strong growth with +95.4% annual revenue expansion. Across his prior four measurable trades at IONQ, Rima was well-timed 50% of the time at the 90-day mark—neither a strong nor weak pattern. His cross-ticker track record shows a 50.00% well-timed rate with an average 90-day return of -6.9% after sells, indicating near-neutral historical timing acumen. With the stock recently up 34.9% over 30 days and 47.0% over 90 days, this sale occurred well into a sustained rally; whether the transaction reflects portfolio rebalancing or conviction about near-term price weakness cannot be determined from the filing alone.

CRO Rima sold 45,000 IONQ shares at $46.18 (now $45.20); extends pattern of 2 recent consecutive sales in June after 112.4% surge.

Rima sold 45,000 shares (7.5% of pre-transaction holdings) on 2025-07-07, extending a pattern of repeated sales: she sold on 2025-06-13 and 2025-06-11 as well, concentrated within the steepest portion of IONQ's 90-day rally (+112.4%). Her prior two trades at IONQ show 2 of 2 well-timed outcomes at the 90-day mark (both resulting in stock declines post-sale), though outcomes for the two June sales remain unmeasurable. At the cross-ticker level, her track record shows a 100% well-timed rate across 4 prior sells, with an average 90-day return of -27.6%, suggesting consistent sell-side timing discipline. IONQ trades 11.5% below its 52-week high ($51.07) despite the substantial recent rally, and the company remains unprofitable with an annual net loss of $-32,252,000 against only $7.6M in latest-quarter revenue, creating fundamental fragility beneath the momentum. The succession of sales within a sharp uptrend and the measurable pattern of earlier profits on sales warrants monitoring for whether the insider perceives deterioration or has identified a pivot point.

CRO Rima sells 84,976 shares ($3.3M) in 2 tranches at $41.60 & $38.57; near 52-week high ($51.07), stock down 25.9%

Rima executed two separate sales totaling 84,976 shares for $3,337,667.21, reducing her holdings by 13.3%. The sales occurred at $41.60 on 2025-06-11 and $38.57 on 2025-06-13, representing a blended average price of $39.28. This timing is notable: the stock traded near its 52-week high of $51.07 when the first tranche sold, and has since declined to $37.84 (currently -25.9% from the 52-week peak). Her prior two sales at IONQ were both well-timed at the 90-day mark (2024-12-11 sale saw 90d return of -37.1%; 2023-12-11 saw 90d return of -18.2%), establishing a pattern of selling before downturns. The company remains unprofitable (net income of $-32,252,000 in the latest quarter) despite strong annual revenue growth of 95.4%, creating a fundamental backdrop of execution risk. The stock has rebounded 13.3% in the past 30 days and 51.4% in 90 days, though this latest filing suggests the CRO's conviction on the equity may warrant investor scrutiny given her historical ability to identify inflection points.

CRO Rima sold 21,337 IONQ shares at $29.73 on 2024-12-11 ($634.4K); stock now $33.83. Prior IONQ sale in Dec 2023 showed -18.2% 90-day return.

Alameddine Rima, Chief Revenue Officer, sold 21,337 shares (a 3.6% reduction from her 592,658-share post-transaction holdings) at $29.73, reducing her stake to 571,321 shares. The current price is $33.83, approximately 13.8% above the sale price. Her prior sale at IONQ on 2023-12-11 was similarly poorly-timed: the stock fell 18.2% in the 90 days following that December 2023 sale, but then recovered in the longer term. The company remains unprofitable with a net loss of $52.5M against quarterly revenue of $12.4M, though it is growing at 98.0% annually. The CRO's second December-timed sale at the same company, occurring when the stock is down 10.9% from its 52-week high despite a 26.4% 30-day rally, occurs in a context where her prior year's same-day-of-month transaction at this ticker underperformed in immediate follow-up trading.